It is the policy of the Association of Diabetes Care & Education Specialists to require that anyone who has an opportunity to affect continuing education activity content (e.g. authors, presenters, and program planners) with products or services from a commercial interest with which s/he has financial relationship/s with commercial entities to participants. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of the presentation.
Relevant disclosures (or lack thereof) among education activity planners and faculty are as follows:
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDE, has disclosed that she has received consulting fees from Dexcom, Novo, and LifeScan.
Vivian A. Fonseca, MD, FRCP, has disclosed that he has received funds for research support (paid to his institution) from Bayer and Boehringer Ingelheim; has received consulting fees from Abbott, Asahi Kasei, AstraZeneca, Intarcia, Lilly, Novo Nordisk, Sanofi, and Takeda; and owns stock or stock options in Amgen, BRAVO4Health, Insulin Algorithms, and Microbiome Technologies.
Pamela Kushner, MD, FAAFP, has disclosed that she has received consulting fees from AstraZeneca, Janssen, Lilly, and Novo Nordisk and fees for non-CME/CE services from AstraZeneca, Janssen, and Novo Nordisk.
Jodi Lavin-Tompkins MSN, RN, CDE, BC-ADM – No conflicts of interest
CLINICAL CARE OPTIONS STAFF
Zachary Schwartz, MSc, has no relevant conflicts of interest to report.
Manager, Editorial Operations
Kiran Mir-Hudgeons, PhD, has no relevant conflicts of interest to report.
Senior Clinical Editor
Megan Cartwright, PhD, has no relevant conflicts of interest to report.
Sharon Hwang, MD MPH, has no relevant conflicts of interest to disclose.
Associate Director, Scientific Services
Carolyn Skowronski, PharmD, has no relevant conflicts of interest to report.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS AND MECHANISM TO IDENTIFY AND RESOLVED CONFLICTS OF INTEREST
Undertaking review of the educational activity by a content reviewer to evaluate for potential bias, balance in presentation, evidence-based content or other indicators of integrity, and absence of bias, AND monitoring the educational activity to evaluate for commercial bias in the presentation, AND reviewing participant feedback to evaluate for commercial bias in the activity.